News: Prostaglandin inhibitors: optimal first-line agents for delaying birth

Article

Although all currently available tocolytic agents perform better than placebo at delaying delivery before 32 weeks' gestation, prostaglandin inhibitors are superior.

Although all currently available tocolytic agents perform better than placebo at delaying delivery before 32 weeks' gestation for both 2 and 7 days, prostaglandin inhibitors are superior, providing the best combination of tolerance and effectiveness. Calcium channel blockers, however, may be superior for delaying delivery until 37 weeks' gestation.

Researchers from Indiana conducted a meta-analysis, which included 58 randomized controlled trials. In terms of delaying delivery for 48 hours, tocolytics were effective 75% to 93% of the time, versus 53% for placebo. For delaying delivery 7 days, tocolytics were effective 61% to 78% of the time, versus 39% for placebo. The authors of the meta-analysis calculated that 80 out of 1,000 women receiving prostaglandin inhibitors would deliver within 48 hours, versus 182 to 416 out of 1,000 for alternative agents.

The studies revealed no significant differences in the incidence of respiratory distress syndrome or neonatal death.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.